Cancer Diagnostics Articles & Analysis
14 articles found
Alfa Cytology has launched ovarian cancer therapy development services. Alfa Cytology, a prominent services provider in oncology, has launched its cutting-edge ovarian cancer therapy development services. ...
Alfa Cytology has announced cancer diagnostic biomarker development services to enhance precision in oncology research. ...
The development principle of cancer vaccines usually includes the identification of antigens, vaccine formulation, immune activation, and targeting of cancer cells. ...
CDH1 acts as a tumor suppressor by inhibiting the Wnt/β-catenin pathway, which is often dysregulated in cancer. What is the role of CDH1 in cancer? The loss or dysfunction of CDH1 has been implicated in the development and progression of various types of cancer. ...
Clarice Reid, a true leader and advocate for those affected by sickle cell disease and BioMark Diagnostics Inc. a diagnostic company focused in developing better cancer care management solutions. ...
As September and Blood Cancer Awareness Month wrap up, we want to reflect on a memorable conversation with Karen Thomas, a woman who received clonoSEQ® testing, and her physician, Dr. ...
The share price has fallen 12% to 220p Cancer diagnostics developer Oncimmune Holdings (LON: ONC) is delaying its 12-month results. ...
SubB2M is an engineered protein that specifically detects the pan-cancer biomarker Neu5Gc that is found at elevated levels in multiple human cancers. ...
The aim of the study is to validate a novel and minimally invasive liquid biopsy test for bladder cancer diagnosis using Nanostics’ ClarityDX® diagnostic platform. ...
I thought back to when my mom was sick, and wished we’d had a modern, more accurate MRD test available at that time for ovarian cancer. The Future of Cancer Diagnostics The diagnostics that we and others are developing measure the genome (an organism’s genes), proteome (proteins expressed by the genome) or the ...
Fluorescence in situ hybridization (FISH) is a technique that prepares acceptable results for molecular imaging biomarkers to precisely and dependably detect and diagnose disorders which are sign of cancers. Since contemporary manual FISH signal analysis is low-effective and inconsistent, it is an attractive research area to develop automated FISH image scanning systems and ...
Exact Imaging is a leading developer of ultra-high-resolution micro-ultrasound diagnostic technologies Micro-ultrasound ExactVu™ is the only ultrasound-based imaging tool with published data demonstrating prostate cancer diagnostic capabilities similar to MRI Combination of Exact Imaging’s micro-ultrasound and EDAP’s Focal ...
The lack of long-term radioactive waste is due to the fact that the Z-Pinch fusion reactor is fueled by an isotope of hydrogen from seawater rather than the highly enriched uranium that fuels the current fission reactor methods used to produce radioisotope products The Current Situation Radioisotopes are an essential part of both cancer treatment and medical ...
The obtained results revealed that magnetic SiO2-coated Fe3O4 nanoparticles can be a promising candidate for the diagnosis of cervical cancer at an early stage with high accuracy.Keywords: magnetic nanoparticles, diagnostics, uterocervical cancer, E coli, monoclonal antibodies, escherichia coli, cervical cancer, diarrhoea, ...